HARMONY BIOSCIENCES HOLDINGS, INC. Acquisitions, Net of Cash Acquired
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Acquisitions, Net of Cash Acquired of $33.07 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-11-04
- HARMONY BIOSCIENCES HOLDINGS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-30 was $0.00.
- HARMONY BIOSCIENCES HOLDINGS, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $36.97M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $33.07M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $33.07M 10-Q · filed 2025-08-05 | |||
| 2023-12-31 | $36.97M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |